news

Waiting on ginning season, Applied DNA dips

Stony Brook-based Applied DNA Sciences reported another down quarter Thursday, with company officials blaming declines on shifting demands for the biotech’s proprietary security solutions. Reporting results for the third quarter…



Sales drop, tax bite sting Chembio Diagnostics

Medford biotech Chembio Diagnostic Systems Inc. took it on the chin in the second quarter, with steep losses attributed to declining sales for its infectious-disease detectors and a one-time, multimillion-dollar…


Stony Brook Medicine, Mount Sinai Health team up

Academic synergies and accelerated discoveries are the promise of a new research collaboration pairing Stony Brook Medicine and the Mount Sinai Health System. Stony Brook University and New York City-based…


Strong 2Q for ageless BioSpecifics Technologies

Significant progress in its clinical-development programs – and a chunky opt-in payment from a major international partner – won’t affect BioSpecifics Technologies Corp.’s financial fortunes until the third quarter, but…








Another strong quarter for Planet Payment

Slight year-over-year declines in net income and earnings dulled Planet Payment’s second-quarter financials, but reported revenues were strong – and the comfortably profitable company remains on-course for significant growth, according…



Sloan Kettering facility green-lighted

The Hempstead Town board approved a site plan for Memorial Sloan Kettering’s proposed $140 million outpatient treatment and research facility at Mitchel Field as part of the so-called Nassau Hub…